Flora T. Musuamba

Scientific and regulatory evaluation of mechanistic <i>in silico</i> drug and disease models in drug development: Building model credibility

Flora T. Musuamba, Ine Skottheim Rusten, R Lesage et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 142 citations · Full text

Pharmacy, Risk Management, Method Validation +11

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico</i> Strategy

Zhihua Li, Gary R. Mirams, Takashi Yoshinaga et al. · Clinical Pharmacology & Therapeutics · 2019 · 116 citations · Full text

Pharmacy, Cardiology, Pharmacology +9

Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study

Frédéric Frippiat, Flora T. Musuamba, Laurence Seidel et al. · Journal of Antimicrobial Chemotherapy · 2014 · 72 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Validation of a Liquid Chromatography-Mass Spectrometric Assay for Tacrolimus in Peripheral Blood Mononuclear Cells

Arnaud Capron, Flora T. Musuamba, Dominique Latinne et al. · Therapeutic Drug Monitoring · 2009 · 62 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus

Flora T. Musuamba, Annick Rousseau, Jean‐Louis Bosmans et al. · Clinical Pharmacokinetics · 2009 · 58 citations

Pharmacy, Pharmacokinetics, Pharmacology +17